FDA has increasingly focused on escalating its enforcement activity against compounded GLP-1 drugs following US President Donald Trumps September 9, 2025, memorandum on prescription drug advertisements, which called on the FDA commissioner and the secretary of the US Department of Health and Human Services (HHS) to take actions to enforce prescription drug advertising laws and regulations
Rybelsus , an oral tablet form of semaglutide, doesnt need refrigeration at all
and Region/Country Geography: Industry: Last Updated: Feb 2025 The GLP-1 Analogues Market was valued at approximately USD 37 Billion in 2023 and is expected to grow at a substantial CAGR of around 28% during the forecast period (2024-2032) owing to the rising prevalence of type 2 diabetes and obesity
T., Rubino, D
GLP-1s mimic natural hormones involved in appetite and glucose regulation, while older medications tend to rely on central nervous system stimulation (like phentermine and Qsymia) or digestive fat-blocking (as with orlistat)
Snchez-Garrido MA, Brandt SJ, Clemmensen C, Mller TD, DiMarchi RD, Tschp MH